- TWD7.50bn
- TWD6.75bn
- TWD7.42bn
- 61
- 76
- 92
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,569 | 6,365 | 6,987 | 7,853 | 7,420 |
Cost of Revenue | |||||
Gross Profit | 1,243 | 1,298 | 1,481 | 1,828 | 1,453 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,992 | 5,700 | 6,238 | 6,824 | 6,690 |
Operating Profit | 577 | 664 | 749 | 1,029 | 730 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 660 | 685 | 865 | 1,097 | 930 |
Provision for Income Taxes | |||||
Net Income After Taxes | 494 | 502 | 596 | 660 | 603 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 445 | 449 | 529 | 573 | 577 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 445 | 449 | 529 | 573 | 577 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.22 | 4.24 | 5.01 | 5.52 | 5.45 |
Dividends per Share |